Latest News

Coaching Boys Into Men Program Proves Effective In Preventing Teen Dating Violence, Follow-Up Study Finds

from MNTpaeds - 02 May 13

Coaching Boys into Men (CBIM), a program that seeks to reduce dating violence and sexual assault, is proven effective to reduce abusive behaviors among male athletes toward their female partners, according to a study that will appear today in the online version of the American Journal of Preventive Medicine. The year-long evaluation study, led by Elizabeth Miller, M.D., Ph.D...

How A Text Message A Day Can Keep The Asthma Attack Away

from MNTpaeds - 02 May 13

Simply sending children with asthma a text message each day asking about their symptoms and providing knowledge about their condition can lead to improved health outcomes...

"Slippery Slope" Fears For Legal Euthanasia Of Very Sick Newborns Unfounded

from MNTpaeds - 02 May 13

Dutch experience shows opposite is true; and parents involved in decisions Fears that legalising euthanasia for very sick newborns would prompt the start of a "slippery slope" and lead to abuse of the option have proved groundless, says the architect of a dedicated protocol used by doctors in The Netherlands, in a special issue of the Journal of Medical Ethics...

Over 4,400 Kids Injured On Amusement Rides Each Year

from MNTpaeds - 01 May 13

Over 4,400 kids are injured on amusement rides each year in the U.S., according to a new study. The research was conducted by scientists in the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital and was published in Clinical Pediatrics...

New Research From The University Of Edinburgh Calls For More To Be Done To Establish Good Eating Habits In Children's Early Years

from MNTpaeds - 01 May 13

New research from The University of Edinburgh has found that in a study of 2000 families with five year olds, those children who eat the same meals as their parents are far more likely to have healthier diets than those who eat different foods...

Defective Protein Largely Responsible For Rare, Lethal Childhood Disease Protein

from MNTpaeds - 01 May 13

A team of international researchers led by Northwestern Medicine scientists has identified how a defective protein plays a central role in a rare, lethal childhood disease known as Giant Axonal Neuropathy, or GAN. The finding is reported in the May 2013 Journal of Clinical Investigation...

Technology, Policy Changes Recommended To Better Protect Older Children And Adolescents In Crashes

from MNTpaeds - 01 May 13

A research report released today from The Children's Hospital of Philadelphia (CHOP) provides specific recommendations for optimizing the rear seat of passenger vehicles to better protect its most common occupants - children and adolescents...

All Adults, Adolescents, And Pregnant Women Should Be Screened For HIV

from MNTpaeds - 01 May 13

New recommendations from the United States Preventive Services Task Force (USPSTF) urge physicians to screen all adults and adolescents aged 15 - 65 for HIV. In addition, all pregnant women should receive screening, even those who are in labor but have not yet been screened. Rapid screening tests and conventional tests are considered equally accurate for screening...

Access To Dermatologists Limited For Medicaid-Insured Children

from MNTpaeds - 01 May 13

A recent Saint Louis University study revealed that Medicaid-insured children with eczema, an inflammatory skin condition that affects 20 percent children in the United States, do not have easy access to dermatologists. "This is a complex problem and a major health disparity in our country," said Elaine Siegfried, M.D., professor of pediatrics at SLU and the principal investigator of the study...

400 IU Of Vitamin D Daily Is Sufficient For Infants

from MNTpaeds - 01 May 13

Babies should be given a daily dose of vitamin D of 400 IU (international units) to help them stay healthy, according to a new study in JAMA. Vitamin D is important for the growth of healthy bones and to prevent rickets, and it is particularly crucial that infants get enough of it during their first year life because their bones are growing very quickly...

Solitary Cerebriform Nodule—Quiz Case

from ArchDerm - 01 May 13

Solitary, Enlarging Painful Violaceous Tumor on the Cheek of a 10-Year-Old—Diagnosis

from ArchDerm - 01 May 13

Solitary, Enlarging Painful Violaceous Tumor on the Cheek of a 10-Year-Old—Quiz Case

from ArchDerm - 01 May 13

Standardizing Training for Psoriasis Measures Effectiveness of an Online Training Video on Psoriasis Area and Severity Index Assessment by Physician and Patient Raters Standardizing Training for Psor

from ArchDerm - 01 May 13

ImportanceBecause the Psoriasis Area and Severity Index (PASI) is the most commonly used and validated disease severity measure for clinical trials, it is imperative to standardize training to ensure reliability in PASI scoring for accurate assessment of disease severity.ObjectiveTo evaluate whether an online PASI training video improves scoring accuracy among patients with psoriasis and physicians on first exposure to PASI.DesignThis equivalency study compared PASI assessment performed by patie

Successful Treatment With Vemurafenib in BRAF V600K–Positive Cerebral Melanoma Metastasis

from ArchDerm - 01 May 13

More than 90% of the BRAF mutations in melanoma are identified at codon 600, and about 80% of these are BRAF V600E mutations. The second most common mutation is the BRAF V600K mutation, representing 14% to 28% of BRAF mutations in melanoma. Vemurafenib treatment for metastatic melanoma has been extensively studied in patients harboring the BRAF V600E mutation. There are rare data concerning the BRAF V600K mutation.

Surgical Excision After Neoadjuvant Therapy With Vismodegib for a Locally Advanced Basal Cell Carcinoma and Resistant Basal Carcinomas in Gorlin Syndrome

from ArchDerm - 01 May 13

Vismodegib is useful to treat locally advanced or metastatic basal cell carcinomas (BCCs), but to our knowledge, its use as a neoadjuvant to shrink BCCs before surgery has not been reported. This case illustrates the role of vismodegib as a neoadjuvant agent. In addition, this case highlights the fact that a patient with Gorlin syndrome can develop resistant BCCs while taking vismodegib, a phenomenon not widely recognized although recently reported.

The American Suntanning Association A “Science-First Organization” With a Biased Scientific Agenda The American Suntanning Association

from ArchDerm - 01 May 13

UV indoor tanning (IT) is a $5 billion-a-year industry in the United States and remains popular despite a growing scientific literature that demonstrates a link between IT and melanoma. The body of evidence linking melanoma to IT has prompted numerous national and international organizations to advocate the avoidance of IT. This list includes the American Medical Association, the American Academy of Dermatology, the US Department of Health and Human Services, and the World Health Organization, a

The Use of Aprepitant in Brachioradial Pruritus

from ArchDerm - 01 May 13

Brachioradial pruritus (BRP) is characterized by intractable itching localized to the dorsolateral aspects of the arms. Aprepitant (Emend; Merck & Co Inc), approved in 2003 for chemotherapy-induced nausea and vomiting, has been used successfully to treat patients with chronic pruritus, but to our knowledge, its use in BRP has not yet been reported.

Tick Removal With Liquid Nitrogen

from ArchDerm - 01 May 13

Lyme disease is a tick-borne zoonosis caused by Borrelia burgdorferi. A causative organism is transmitted via tick bite, Ixodes ricinus in Europe and neighboring parts of North Africa, and Ixodes scapularis and Ixodes pacificus on the west coast of North America. Erythema chronicum migrans is the first, the most common, and the most specific clinical manifestation and a defining criterion for Lyme disease.

Top-Accessed Article: Text-Message Reminders to Improve Sunscreen Use

from ArchDerm - 01 May 13

Armstrong AW, Watson AJ, Makredes M, Frangos JE, Kimball AB, Kvedar JC. Text-message reminders to improve sunscreen use: a randomized, controlled trial using electronic monitoring. Arch Dermatol. 2009;145(11):1230-1236.

Topical Tazarotene for the Treatment of Ectropion in Ichthyosis Topical Tazarotene for Ectropion in Ichthyosis

from ArchDerm - 01 May 13

ImportanceEctropion is a complication of certain subtypes of ichthyosis and is often associated with substantial medical and cosmetic consequences. At present there is no standard of care for the treatment of ectropion in this population. Retinoids cause dyshesion and thinning of stratum corneum, thereby reducing hyperkeratosis that likely underlies ectropion in patients with ichthyosis. As such, retinoids provide a potential effective treatment for ectropion in this group of patients.Observatio

Toward a Better Definition of High-Risk Cutaneous Squamous Cell Carcinoma Comment on “Factors Predictive of Recurrence and Death From Cutaneous Squamous Cell Carcinoma” High-Risk Cutaneous Squamous C

from ArchDerm - 01 May 13

Patient prognosis varies considerably among various types of skin cancer. Approximately 5% of cutaneous squamous cell carcinomas (CSCCs) metastasize, usually to regional nodes. A recent staging system has been developed for CSCC that combines tumor diameter with high-risk features, including primary tumor size greater than 2 cm, Breslow thickness greater than 2 mm, Clark level IV or greater, perineural invasion, poor differentiation, and primary site on the ear or lip, to classify tumors as T1 o

Update on Metastatic Basal Cell Carcinoma: A Summary of Published Cases From 1981 Through 2011

from ArchDerm - 01 May 13

While basal cell carcinoma (BCC) is the most common cancer in the United States, metastasis (mBCC) is extremely rare, with an incidence of 0.0028% to 0.55%. The most recent review of mBCC cases from 1894 through 1980 by von Domarus and Stevens is now 30 years old. We conducted a retrospective systematic evaluation of all published mBCC cases from 1981 through 2011 to update patient demographics and tumor characteristics associated with mBCC and to determine whether adjuvant therapy was associate

Use of Sunlight to Treat Dyshidrotic Eczema

from ArchDerm - 01 May 13

Dyshidrotic eczema is a common complaint. It is very often chronic with recurrences. Although no direct cause of the condition has been identified, immunologic reactions are suggested as a symptom-generating mechanism.

Ustekinumab Therapy for Severe Interstitial Granulomatous Dermatitis With Arthritis

from ArchDerm - 01 May 13

Interstitial granulomatous dermatitis with arthritis (IGDA) is a rare disease that was first described by Ackerman in 1993. Fewer than 70 cases have been reported in the literature, and specific therapies are not available. We report here a case of severe recalcitrant IGDA that was successfully treated with ustekinumab.